SUMMARY Patients who undergo cardiac catheterization are frequently taking propranolol and are often premedicated with diazepam. Because the intensity of a drug's action is determined by free, or non-proteinbound, levels in plasma, changes in the degree of protein binding may profoundly alter the pharmacologic effect. We examined the effects of heparin on the free levels of propranolol and diazepam in six patients who underwent cardiac catheterization. After heparinization, the free fraction of diazepam increased more than fourfold, from 1.8 ± 0.1% to 7.9 ± 1.2% (p < 0.002) and the free levels increased from 2.0 ± 0.5 to 8.4 ± 2.2 ng/ml (p < 0.025); the free fraction of propranolol increased from 7.4 ± 0.9% to 12.5 ± 1.4% (p < 0.001). The increase in free drug concentration was associated with elevated free fatty acid levels, which rose from 181 7 gg/ml to 596 ± 119 ,ug/ml (p < 0.02). Increases in the free levels of propranolol and diazepam produced by heparinization during cardiac catheterization may result in increased pharmacologic effect, such as excessive sedation or respiratory depression.
ALTHOUGH total plasma drug concentrations are monitored to determine individual drug dosages, only the free or non-protein-bound fraction of total drug in plasma is available for extravascular distribution and binding to receptor sites and exerting pharmacologic effect. Small increases in the free fraction of highly plasma bound drugs, such as propranolol and diazepam, produce significant changes in free concentration and therefore increase the drug's pharmacologic activity. An excellent correlation (r = 0.89, p < 0.001) has been shown between the free, or unbound, concentration of propranolol in plasma and its ability to antagonize the effects of isoproterenol.' In addition, changes in the plasma binding of a drug may significantly influence drug disposition. If the clearance of a drug is limited by protein binding (restrictive elimination), changes in this binding may alter clearance and chronic total steady-state drug 2 concentrations.
Although heparin administration increases the free fraction of propranolol3 4 and is associated with an increase in free fatty acid concentrations, the clinical importance of this finding has not been examined.
Heparin is routinely administered as an anticoagulant during many procedures, including hemodialysis and cardiac catheterization. We studied the effects of heparjnization during cardiac catheterization on the free fraction of propranolol and diazepam. Changes in drug binding have usually been shown in vitro and measurements in vivo have included only total drug concentration in blood or plasma. Therefore, to determine the clinical relevance of alterations in free fraction, we also studied the effects of cardiac catheterization on the free levels of propranolol and diazepam.
Patients and Methods
We studied six patients ages 35-64 years (four females and two males) who were undergoing cardiac catheterization. Informed consent and the approval of the Institutional Review Board were obtained. Three of the patients had been taking oral propranolol chronically before cardiac catheterization, and five patients received 10 mg of diazepam by intramuscular injection before the procedure. All six patients had fasted for at least 8 hours before catheterization. The patients received 10-20 ml of 1% lidocaine locally infiltrated into the groin before catheterization. Immediately after insertion of the cardiac catheter, 3000 IU of heparin were administered. Blood samples were collected in heparinized glass-stoppered tubes (in vitro heparin has no effect on drug binding3) at the start of the procedure, after the administration of lidocaine, after insertion of the cardiac catheter but before heparinization and 5 minutes after administration of heparin to measure propranolol and diazepam binding, free fatty acid levels and total plasma propranolol and diazepam levels. Plasma binding of propranolol was measured on all samples by equilibrium dialysis within 2 hours of sampling. 3H-propranolol (1.9 ng) (specific activity 81 mCi/mg) in saline was added to 1.0 ml of phosphate buffer in a dialysis cell (Spectrum Medical Industries), with 1.0 ml of plasma on the other side of the dialysis membrane, as previously described.4' 8 The cells were then rotated at 15 rpm in a water bath at 37°C for 4 hours, by which time -equilibrium had been reached.
The free fraction of propranolol in plasma was calculated as the concentration of radioactive propranolol in the buffer divided by the concentration VOL 62, No 5, NOVEMBER 1980 in the plasma. The binding of diazepam was measured by equilibrium dialysis in a similar manner except that 0.75 ng of 3H-diazepam (specific activity 83.5 Ci/ mmol) was added to the buffer. Free fatty acid levels were estimated by the method of Dole and Meinertz.9 Total propranolol concentrations in plasma were measured by high-performance liquid chromatography using the method of Wood et al. 10 Total plasma levels of diazepam were determined by high-performance liquid chromatography after solvent extraction. One gg of demoxepam and 1 ml of saturated aqueous sodium borate solution were added to 1 ml of plasma and extracted with 5 ml of chloroform. After centrifugation, the chloroform was evaporated to dryness, the residue was reconstituted with 100 gl of chromatographic mobile phase and 25 gl were injected into the chromatogram. Analyses were performed using an M6000 solvent delivery system, a U6K injector and a C8, M-Bondapak column (300 mm X 3.9 mm i.d.) (Waters Associates) and a mobile phase of methanol and water (65:35) at a flow rate of 2.0 mi/min. The free concentrations of diazepam and propranolol in plasma were then calculated from a knowledge of free fraction and total drug concentration in plasma as: free concentration = total drug concentration X free fraction.
Samples of blood for estimation of plasma epinephrine and norepinephrine concentrations were also taken at the start of the procedure, after the administration of local anesthesia, after insertion of the cardiac catheter and after the administration of heparin. These samples were collected in tubes containing reduced glutathione, kept in ice until centrifuged, and then assayed for norepinephrine and epinephrine using a modification of the technique of Passon and Peuler,' in which the methylated derivatives of catecholamines were produced in the presence of catechol-0-methyltransferase and tritiated S-adenosylmethionine and then separated by thinlayer chromatography.
The data were analyzed using a paired t test; p < 0.05 was considered statistically significant.
Results
The free fractions of diazepam and propranolol did not change during the start of the procedure, administration of local anesthetic and insertion of the cardiac catheter. However, after the administration of heparin, the free fraction of propranolol increased in the six patients from 7.4 ± 0.88 (mean ± SEM) to 12.5 ± 1.4% (p < 0.001) and the free fraction of diazepam increased more than fourfold from 1.8 ± 0.11 to 7.9 ± 1.16% (p < 0.002) ( fig. 1) .
The free levels of propranolol in the three patients who were taking propranolol increased from 1.7 ± 0.4 to 2.7 ± 0.6 ng/ml, and the free level of diazepam in the five patients premedicated with diazepam increased fourfold, from 2.04 ± 0.47 to 8.39 ± 2. 119 pg/ml ( fig. 3) . The norepinephrine and epinephrine concentrations did not change significantly during the procedure ( This study shows that the clinical use of heparin during cardiac catheterization increases not only the free fraction but also the free levels of diazepam and propranolol. Although increases in the free fraction of drugs after administration of heparin have been shown,3 4speculation regarding the effects of altered disposition on plasma drug levels has prevented the confident extrapolation of the results to clinical situations. However, it is clear from this study that, at least acutely, heparin administration can result in the elevation of free levels of diazepam. Heparin raises the level of circulating free fatty acids because it increases lipoprotein lipase activity;12 we have shown a correlation between the elevated free fraction of propranolol after heparin administration and free fatty acid levels,' consistent with the view that free fatty acids can affect drug binding. Spector care should be taken during the administration of heparin to monitor for the possibility of suddenly increased drug effects. Our results emphasize the importance of measuring free drug levels rather than total drug levels when studying drug effects in electrophysiologic and hemodynamic studies during cardiac catheterization because large changes in drug binding can occur during this procedure. In this study, we have shown that it is misleading to extrapolate the results of drug studies performed during cardiac catheterization to the usual heparin-free clinical situation if alterations in drug binding are not taken into account.
